<SEC-DOCUMENT>0001564590-19-012607-index.html : 20190424
<SEC-HEADER>0001564590-19-012607.hdr.sgml : 20190424
<ACCEPTANCE-DATETIME>20190424080858
ACCESSION NUMBER:		0001564590-19-012607
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190423
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190424
DATE AS OF CHANGE:		20190424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Menlo Therapeutics Inc.
		CENTRAL INDEX KEY:			0001566044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				453757789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38356
		FILM NUMBER:		19762649

	BUSINESS ADDRESS:	
		STREET 1:		200 CARDINAL WAY, 2ND FLOOR
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063
		BUSINESS PHONE:		650-486-1416

	MAIL ADDRESS:	
		STREET 1:		200 CARDINAL WAY, 2ND FLOOR
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Menlo Therapeutics, Inc.
		DATE OF NAME CHANGE:	20170728

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tigercat Pharma, Inc.
		DATE OF NAME CHANGE:	20130104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mnlo-8k_20190423.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: mnlo-8k_20190423.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>mnlo-ex101_17.htm
<DESCRIPTION>EX-10.1
<TEXT>
Document 2 - file: mnlo-ex101_17.htm

</DOCUMENT>
</SEC-DOCUMENT>